Reliability and Validity of the CogState Battery Chinese Language Version in Schizophrenia
Open Access
- 2 September 2013
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (9) , e74258
Abstract
Cognitive impairment in patients with schizophrenia is a core symptom of this disease. The computerized CogState Battery (CSB) has been used to detect seven of the most common cognitive domains in schizophrenia. The aim of this study was to examine the reliability and validity of the Chinese version of the CSB (CSB-C), in Chinese patients with schizophrenia. Sixty Chinese patients with schizophrenia and 58 age, sex, and education matched healthy controls were enrolled. All subjects completed the CSB-C and the Repeated Battery for the Assessment of Neuropsychological Status (RBANS). To examine the test-retest reliability of CSB-C, we tested 33 healthy controls twice, at a one month interval. The Cronbach α value of CSB-C in patients was 0.81. The test-retest correlation coefficients of the Two Back Task, Gronton Maze Learning Task, Social Emotional Cognition Task, and Continuous Paired Association Learning Task were between 0.39 and 0.62 (p<0.01) in healthy controls. The composite scores and all subscores for the CSB-C in patients were significantly (p<0.01) lower than those of healthy controls. Furthermore, composite scores for patients on the RBANS were also significantly lower than those of healthy controls. Interestingly, there was a positive correlation (r = 0.544, p<0.001) between the composite scores on CSB-C and RBANS for patients. Additionally, in the attention and memory cognitive domains, corresponding subsets from the two batteries correlated significantly (p<0.05). Moreover, factor analysis showed a two-factor model, consisting of speed, memory and reasoning. The CSB-C shows good reliability and validity in measuring the broad cognitive domains of schizophrenia in affected Chinese patients. Therefore, the CSB-C can be used as a cognitive battery, to assess the therapeutic effects of potential cognitive-enhancing agents in this cohort.Keywords
This publication has 55 references indexed in Scilit:
- A meta-analysis of the effects of chemotherapy on cognition in patients with cancerCancer Treatment Reviews, 2013
- Adaptive Associations between Social Cognition and Emotion Regulation are Absent in Schizophrenia and Bipolar DisorderFrontiers in Psychology, 2013
- Cognitive Remediation in SchizophreniaClinical Psychopharmacology and Neuroscience, 2012
- Decreased Serum Levels of Mature Brain-Derived Neurotrophic Factor (BDNF), but Not Its Precursor proBDNF, in Patients with Major Depressive DisorderPLOS ONE, 2012
- Cigarette Smoking and Cognitive Function in Chinese Male Schizophrenia: A Case-Control studyPLOS ONE, 2012
- Quality of life of Chinese urban community residents: a psychometric study of the mainland Chinese version of the WHOQOL-BREFBMC Medical Research Methodology, 2012
- Criterion and Construct Validity of the CogState Schizophrenia Battery in Japanese Patients with SchizophreniaPLOS ONE, 2011
- The FDA-NIMH-MATRICS Guidelines for Clinical Trial Design of Cognitive-Enhancing Drugs: What Do We Know 5 Years Later?Schizophrenia Bulletin, 2010
- The Effect of Context Processing on Different Aspects of Social Cognition in SchizophreniaSchizophrenia Bulletin, 2010
- Static and Dynamic Cognitive Deficits in Childhood Preceding Adult Schizophrenia: A 30-Year StudyAmerican Journal of Psychiatry, 2010